Lonsurf

Active Ingredient(s): Trifluridine + Tipiracil
FDA Approved: * September 22, 2015
Pharm Company: * TAIHO ONCOLOGY INC
Category: Cancer

Trifluridine/tipiracil, sold under the brand name Lonsurf, is a fixed-dose combination medication that is used as a third- or fourth-line treatment of metastatic colorectal cancer or gastric cancer, after chemotherapy and targeted therapeutics have failed.[2][3] It is a combination of two active pharmaceutical ingredients: trifluridine, a nucleoside analog, and tipiracil, a thymidine phosphorylase inhibitor.[2][3] Tipiracil prev... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Lonsurf Oral Tablet, Film Coated
NDC: 64842-1020
Labeler:
Taiho Pharmaceutical Co., Ltd.
Lonsurf Oral Tablet, Film Coated
NDC: 64842-1025
Labeler:
Taiho Pharmaceutical Co., Ltd.